• Home
  • >
  • Indrayani Biotech Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/indrayani-biotech-ltd.png Logo

Indrayani Biotech Ltd Financial Statement

Indrayani Biotech Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Dec 2023Sep 2023Jun 2023
Revenue13.7716.116.82
Operating Expense12.3614.7114.79
Net Profit0.260.410.72
Net Profit Margin1.892.554.28
Earning Per Share0.060.120.21
EBIDTA1.411.42.04
Effective Tax RateTBATBATBA

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Indrayani Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual162.9361.5721.09
Operating Expenses Annual145.754.826.04
Operating Profit Annual21.216.98-8.79
Interest Annual5.561.881.96
Depreciation3.350.660.46
Net Profit Annual11.934.44-11.21
Tax Annual0.38TBATBA

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Indrayani Biotech Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning1.50.681.4
Cash Flow from Operations16.194.110.26
Cash Flow from Investing-47.39-0.56-0.7
Cash Flow from Financing32.74-2.73-0.28
Cash Flow at the End3.041.50.68

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Indrayani Biotech Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)13.0711.35-22.19
PBIT Margin (%)11.0110.28-24.37
PBT Margin (%)6.744.5-11.99
Net PROFIT Margin (%)6.797.29-51.83
Return On Networth / Equity (%)29.3116.46TBA
Return On Networth /Employed(%)19.9814.34TBA
Return On Assets (%)13.6611.38-27.47
Total Debt / Equity(X)0.810.730.57
Asset Turnover Ratio (%)2.011.560.53

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Indrayani Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual57.4816.5115.37
Total Current Assets Annual77.5218.919.15
Non Current Assets Annual78.4432.4930.9
Total Shareholders Funds Annual55.0924.1619.72
Total Assets Annual155.9651.440.05

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Indrayani Biotech Ltd Earning Calls
Dec 2023
EPS beaten by -8.33 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Indrayani Biotech Ltd has a market capitalization of 193.42 Cr. Value Research classifies it as a Micro-Cap company.

No, Indrayani Biotech Ltd is not debt-free with a debt-to-equity ratio of 1.20.

In FY 2023, Indrayani Biotech Ltd recorded a total revenue of approximately 162.93 Cr marking a significant milestone in the company's financial performance.

Indrayani Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 1.1% and 1.0% annually, respectively..

Indrayani Biotech Ltd's current PE ratio is 22.13.

Indrayani Biotech Ltd's ROCE averaged 4.7% from the FY ending March 2021 to 2023, with a median of 14.0%. It peaked at 14.7% in March 2022, reflecting strong capital efficiency over the period..

Indrayani Biotech Ltd's latest EBIT is Rs. 17.87 Cr, surpassing the average EBIT of Rs. 4.98 Cr over the 5 years..